MD; Xu Liu

Prof. MD; Xu Liu


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Life Sciences
Verified
Journal Article
Closed access
RLRongjie Lin
Rongjie Lin
SWShaohui Wu
Shaohui Wu
DZDan Zhu
Dan Zhu
MQMu Qin
Mu Qin
MLMD; Xu Liu
MD; Xu Liu

1 September 2017 in JACC: Clinical Electrophysiology
Verified
Journal Article
Closed access
MQMu Qin
Mu Qin
YZYu Zhang
Yu Zhang
MLMD; Xu Liu
MD; Xu Liu
WJWei-Feng Jiang
Wei-Feng Jiang
SWShao-Hui Wu
Shao-Hui Wu
SPSunny Po
Sunny Po

30 April 2019 in Clinical Cardiology
Verified
Journal Article
Open access
PDF file
MQMu Qin
Mu Qin
CZCong Zeng
Cong Zeng
MLMD; Xu Liu
MD; Xu Liu
The cardiac autonomic nerve system (CANS) is a potentially potent modulator of the initiation and perpetuation of atrial fibrillation (AF). In this review, we focus on the relationship between the autonomic nervous system (ANS) and the pathophysiology of AF and the potential benefit and limitations of neuromodulation in the management of this arrhythmia from eight aspects. We conclude that Activation and Remodeling of CANS involved in the initiation and maintenance of AF. The network control mechanism, innervation regions, and sympathetic/parasympathetic balance play an important role in AF substrate. And the formation of Complex Fractional Atrial Electrograms also related to CANS activity. In addition, modulating CANS function by potential therapeutic applications include ganglionated plexus ablation, renal sympathetic denervation, and low‐level vagal nerve stimulation, may enable AF to be controlled. Although the role of the ANS has long been recognized, a better understanding of the complex interrelationships of the various components of the CANS will lead to improvement of treatments for this common arrhythmia.

13 April 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
KLKaige Li
Kaige Li
CXChanghao Xu
Changhao Xu
XZXiyao Zhu
Xiyao Zhu
XWXinhua Wang
Xinhua Wang
PYPing Ye
Ping Ye
MLMD; Xu Liu
MD; Xu Liu
The optimal strategy for persistent atrial fibrillation (PerAF) is poorly defined. We conducted a multicentre, randomized, prospective trial to compare the outcomes of different ablation strategies for PerAF. We enrolled 450 patients and randomly assigned them in a 1:1:1 ratio to undergo pulmonary vein isolation and subsequently undergo the following three different ablation strategies: anatomical guided ablation (ANAT group, n = 150), electrogram guided ablation (EGM group, n = 150), and extensive electro-anatomical guided ablation (EXT group, n = 150). The primary endpoint was freedom from atrial fibrillation (AF) lasting longer than 30 s at 12 months after a single ablation procedure. After 12 months of follow-up, 72% (108) of patients in the EXT group were free from AF recurrence, as compared with the 64% (96) in the EGM group (P = 0.116), and 54% (81) in the ANAT group (P = 0.002). The EXT group showed less AF/atrial tachycardia recurrence than the EGM group (60% vs. 50%, P = 0.064) and the ANAT group (60% vs. 37.3%, P < 0.001). The EXT group showed the highest rate of AF termination (66.7%), followed by 56.7% in the EGM group, and 20.7% in the ANAT group. The AF termination signified less AF recurrence at 12 months compared to patients without AF termination (30.1% vs. 42.7%, P = 0.008). Safety endpoints did not differ significantly between the three groups (P = 0.924). Electro-anatomical guided ablation achieved the most favourable outcomes among the three ablation strategies. The AF termination is a reliable ablation endpoint. Extensive electro-anatomical guided ablation for persistent atrial fibrillation.

1 May 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
MQMu Qin
Mu Qin
MLMD; Xu Liu
MD; Xu Liu
WJWei-Feng Jiang
Wei-Feng Jiang
SWShao-Hui Wu
Shao-Hui Wu
XZXiao-Dong Zhang
Xiao-Dong Zhang
SPSunny Po
Sunny Po

3 February 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
CXChang-Hao Xu
Chang-Hao Xu
FXFeng Xiong
Feng Xiong
WJWei-Feng Jiang
Wei-Feng Jiang
MLMD; Xu Liu
MD; Xu Liu
TLTao Liu
Tao Liu
MQMu Qin
Mu Qin
Treatment of atrial fibrillation (AF) remains challenging despite significant progress in understanding its underlying mechanisms. The first detailed, quantitative theory of functional re-entry, the ‘leading circle’ model, was developed more than 40 years ago. Subsequently, in decades of study, an alternative paradigm based on spiral waves has long been postulated to drive AF. The rotor as a ‘spiral wave generator’ is a curved ‘vortex’ formed by spin motion in the two-dimensional plane, identified using advanced mapping methods in experimental and clinical AF. However, it is challenging to achieve complementary results between experimental results and clinical studies due to the limitation in research methods and the complexity of the rotor mechanism. Here, we review knowledge garnered over decades on generation, electrophysiological properties, and three-dimensional (3D) structure diversity of the rotor mechanism and make a comparison among recent clinical approaches to identify rotors. Although initial studies of rotor ablation at many independent centres have achieved promising results, some inconclusive outcomes exist in others. We propose that the clinical rotor identification might be substantially influenced by (i) non-identical surface activation patterns, which resulted from a diverse 3D form of scroll wave, and (ii) inadequate resolution of mapping techniques. With rapidly advancing theoretical and technological developments, future work is required to resolve clinically relevant limitations in current basic and clinical research methodology, translate from one to the other, and resolve available mapping techniques.